Aemetis (NASDAQ:AMTX) Given New $22.00 Price Target at Ascendiant Capital Markets

Aemetis (NASDAQ:AMTX) had its price target boosted by stock analysts at Ascendiant Capital Markets from $21.00 to $22.00 in a research note issued on Friday,Benzinga reports. The firm presently has a “buy” rating on the specialty chemicals company’s stock.

Other equities analysts also recently issued research reports about the stock. Wall Street Zen raised shares of Aemetis from a “sell” rating to a “hold” rating in a research note on Sunday, May 17th. Loop Capital set a $1.75 price target on shares of Aemetis in a research note on Thursday, March 12th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Aemetis in a research note on Monday, April 20th. Two investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Aemetis currently has a consensus rating of “Hold” and an average price target of $8.92.

Aemetis Trading Up 4.7%

Shares of AMTX stock opened at $2.25 on Friday. The company’s fifty day simple moving average is $2.66 and its 200-day simple moving average is $1.96. Aemetis has a 52 week low of $1.30 and a 52 week high of $3.80. The company has a market cap of $158.33 million, a PE ratio of -1.89 and a beta of 1.46.

Aemetis (NASDAQ:AMTX) last issued its earnings results on Thursday, May 7th. The specialty chemicals company reported ($0.33) EPS for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.06). The firm had revenue of $54.62 million for the quarter, compared to analyst estimates of $66.70 million. Equities research analysts expect that Aemetis will post -1.03 EPS for the current fiscal year.

Institutional Investors Weigh In On Aemetis

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Bank of America Corp DE increased its position in shares of Aemetis by 148.3% in the 1st quarter. Bank of America Corp DE now owns 101,486 shares of the specialty chemicals company’s stock worth $324,000 after purchasing an additional 60,611 shares during the last quarter. Royal Bank of Canada increased its position in shares of Aemetis by 10,632.5% in the 1st quarter. Royal Bank of Canada now owns 8,908 shares of the specialty chemicals company’s stock worth $28,000 after purchasing an additional 8,825 shares during the last quarter. Renaissance Technologies LLC bought a new stake in shares of Aemetis in the 1st quarter worth about $272,000. Sanctuary Advisors LLC bought a new stake in shares of Aemetis in the 1st quarter worth about $33,000. Finally, Patriot Financial Group Insurance Agency LLC bought a new stake in shares of Aemetis in the 1st quarter worth about $117,000. Institutional investors own 27.02% of the company’s stock.

About Aemetis

Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.

Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.